Yayınlar & Eserler

Makaleler 65
Tümü (65)
SCI-E, SSCI, AHCI (55)
SCI-E, SSCI, AHCI, ESCI (56)
ESCI (1)
Scopus (57)
TRDizin (10)
Diğer Yayınlar (5)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 73

5. Distribution of immune cell groups and cytokine levels in MS patients under ocrelizumab treatment

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.1013-1014, (Özet Bildiri) identifier

7. The Effect of Multiple Sclerosis Sera on Pericyte Survival

9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.825-826, (Özet Bildiri) identifier

9. Silencing KCNS3 and FCRLB Genes in Experimental Model of MuSK Myasthenia Gravis: Two Novel Molecules in MG Pathogenesis

5th International Molecular Immunology and Immunogenetics Congress (MIMIC V), İzmir, Türkiye, 20 - 22 Ekim 2022, ss.14, (Özet Bildiri)

11. MuSK Myasthenia Gravis fare modelinde KCNS3 ve FCRLB genlerinin susturulması

20. Ulusal Sinirbilim Kongresi, İstanbul, Türkiye, 19 - 23 Ekim 2022, ss.98, (Özet Bildiri)

12. Silencing KCNS3 And FCRLB Genes İn The Experimental Model Of Musk Myasthenia Gravis: Two Novel Molecules in MG Pathogenesis

5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Türkiye, 20 - 22 Ekim 2022, (Tam Metin Bildiri)

19. The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker.

15th International Society of Neuroimmunology (ISNI) Congress, Antibes, Fransa, 8 - 12 Kasım 2021, ss.45, (Özet Bildiri)

20. The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker

15th International Society of Neuroimmunology (ISNI) Congress, France (Virtual)., 8 - 12 Kasım 2021, (Tam Metin Bildiri)

21. Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?

15th International Society of Neuroimmunology (ISNI) Congress, Nice, Fransa, 8 - 12 Kasım 2021, (Yayınlanmadı)

25. Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Danimarka, ss.450, (Tam Metin Bildiri)

27. SCREENING OF AUTO-ANTIBODIES AGAINST CALCIUM CHANNELS IN PATIENTS WITH ABSENCE EPILEPSY

30th International Epilepsy Congress, Kanada, ss.138, (Tam Metin Bildiri)

31. The role of pericytes in MS pathophysiology.

VII. International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 07 Eylül 2019, ss.92-15, (Özet Bildiri)

32. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis (P4.2-048)

71st Annual Meeting of the American-Academy-of-Neurology, Philadelphia, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, (Özet Bildiri)

33. Serum Levels of Inflammasome Complex Factors are Suppressed in Focal Epilepsy Patients

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri) identifier

34. The Role of Pericytes in the Pathophysiology Multiple of Sclerosis

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri) identifier

35. Serum levels of inflammasome complex factors are suppressed in focal epilepsy patients

AAN 71st Annual Meeting, Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, ss.92-15, (Özet Bildiri)

36. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri) identifier

37. Multiple Skleroz Patofizyolojisinde Perisitlerin Rolü

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2019, (Yayınlanmadı)

38. Fokal Epilepsilerde İnflamazomun Rolü

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Yayınlanmadı)

44. Association between inflammatory markers and cognitive outcome in patients with acute brain dysfunction due to sepsis

. 38th International Symposium on Intensive Care and Emergency Medicine , Brussels, Belçika, 20 - 23 Mart 2018, ss.7, (Özet Bildiri)

47. Brain magnetic resonance imaging findings in patients with septic shock

36th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belçika, 15 - 18 Mart 2016, cilt.20, sa.94, ss.134, (Özet Bildiri) Creative Commons License

48. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis

International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Türkiye, 27 - 30 Nisan 2016, cilt.4, ss.75, (Tam Metin Bildiri)

51. Evaluation of Paraoxonase 1 Polymorphisms in Patient with Bipolar Disorder.

V. International Congress of Molecular Medicine, İzmir, Türkiye, 20 - 22 Mayıs 2015, ss.1, (Tam Metin Bildiri)

52. COX-2 Gene Variants in Bipolar Disorder-1.

V. International Congress of Molecular Medicine, İzmir, Türkiye, 20 - 22 Mayıs 2015, ss.1, (Tam Metin Bildiri)

55. Nöromyelitis Optika ve Otoimmün Ensefalitte Serum Oreksin-A Düzeyleri.

50. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 21 - 27 Kasım 2014, ss.1, (Tam Metin Bildiri)

56. Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.228, (Özet Bildiri) identifier

58. Mitochondrial carrier 1 (MTCH1) antibodies in neuromyelitis optica patients with or without aquaporin-4 antibodies

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japonya, 6 - 08 Kasım 2013, cilt.20, ss.942-943, (Özet Bildiri) identifier

62. Evaluation of anti-neuronal autoimmunity in migraine patients with white matter lesions

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri) identifier

63. Gene expression profiles in neuro-Behcet's disease during active and inactive stages

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, ss.379, (Özet Bildiri) identifier

64. Gene expression profiles in neuro-Behcet's disease during active and inactive stages

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, (Özet Bildiri) identifier

66. Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

68. Amyotrofik Lateral Skleroz ALS da Serum Anti Nöronal Antikorları

11. Ulusal Sinirbilim Kongresi (11th Turkish Neuroscience Congress), Türkiye, 28 Nisan 2013

71. Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80, (Özet Bildiri) identifier

72. Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses

11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.8, (Özet Bildiri) identifier

73. Skeletal muscle pathology in the experimental animal model of muscle-specific receptor tyrosine kinase (MuSK) related myasthenia gravis

11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.51-52, (Özet Bildiri) identifier
Kitaplar 3

1. Voltaja Bağımlı Membran Potansiyeli

Nörologlar için Nörobilim, Müge Yemişçi,Hülya Karataş-Kurşun,Cem İsmail Küçükali,Erdem Tüzün,Birgül Baştan, Editör, Bayçınar Tıbbi Yayıncılık, Ankara, ss.69-77, 2024

2. The Experimental Animal Models for the Research of Neuroimmunological Diseases

Current Trends in Neurosciences, ORHAN NURCAN, KARAKAŞ ZEYNEP, DEMİRALP TAMER, Editör, Istanbul University Press, İstanbul, ss.37-61, 2024

3. Miyastenia gravis modeli

Temel ve Klinik Nöroimmünoloji, Karabudak R, Editör, Ada Yayıncılık, İstanbul, ss.165-173, 2013
Metrikler

Yayın

141

Yayın (WoS)

70

Yayın (Scopus)

57

Atıf (WoS)

686

H-İndeks (WoS)

10

Atıf (Scopus)

769

H-İndeks (Scopus)

18

Atıf (Scholar)

246

H-İndeks (Scholar)

9

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Sobiad)

39

H-İndeks (Sobiad)

2

Atıf (Diğer Toplam)

1

Proje

20

Açık Erişim

11
BM Sürdürülebilir Kalkınma Amaçları